GIPC1 regulates MACC1-driven metastasis Article Swipe
Franziska Siegel
,
Hannes Schmidt
,
Manisha Juneja
,
Janice Smith
,
Pia Herrmann
,
Dennis Kobelt
,
Kamal Sharma
,
Iduna Fichtner
,
Wolfgang Walther
,
Gunnar Dittmar
,
Rudolf Volkmer
,
Fritz G. Rathjen
,
Peter M. Schlag
,
Ulrike Stein
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.3389/fonc.2023.1280977
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.3389/fonc.2023.1280977
Background Identification of cancer metastasis-relevant molecular networks is desired to provide the basis for understanding and developing intervention strategies. Here we address the role of GIPC1 in the process of MACC1-driven metastasis. MACC1 is a prognostic indicator for patient metastasis formation and metastasis-free survival. MACC1 controls gene transcription, promotes motility, invasion and proliferation of colon cancer cells in vitro , and causes tumor growth and metastasis in mice. Methods By using yeast-two-hybrid assay, mass spectrometry, co-immunoprecipitation and peptide array we analyzed GIPC1 protein binding partners, by using the MACC1 gene promoter and chromatin immunoprecipitation and electrophoretic mobility shift assay we probed for GIPC1 as transcription factor. We employed GIPC1/MACC1-manipulated cell lines for in vitro and in vivo analyses, and we probed the GIPC1/MACC1 impact using human primary colorectal cancer (CRC) tissue. Results We identified MACC1 and its paralogue SH3BP4 as protein binding partners of the protein GIPC1, and we also demonstrated the binding of GIPC1 as transcription factor to the MACC1 promoter (TSS to -60 bp). GIPC1 knockdown reduced endogenous, but not CMV promoter-driven MACC1 expression, and diminished MACC1-induced cell migration and invasion. GIPC1 suppression reduced tumor growth and metastasis in mice intrasplenically transplanted with MACC1-overexpressing CRC cells. In human primary CRC specimens, GIPC1 correlates with MACC1 expression and is of prognostic value for metastasis formation and metastasis-free survival. Combination of MACC1 and GIPC1 expression improved patient survival prognosis, whereas SH3BP4 expression did not show any prognostic value. Conclusions We identified an important, dual function of GIPC1 - as protein interaction partner and as transcription factor of MACC1 – for tumor progression and cancer metastasis.
Related Topics
Concepts
Metastasis
Gene knockdown
Chromatin immunoprecipitation
Cancer research
Transcription factor
Immunoprecipitation
Colorectal cancer
Biology
Electrophoretic mobility shift assay
Promoter
Chemistry
Gene
Gene expression
Cancer
Genetics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3389/fonc.2023.1280977
- https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1280977/pdf
- OA Status
- gold
- Cited By
- 1
- References
- 47
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4389479645
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4389479645Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fonc.2023.1280977Digital Object Identifier
- Title
-
GIPC1 regulates MACC1-driven metastasisWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-12-08Full publication date if available
- Authors
-
Franziska Siegel, Hannes Schmidt, Manisha Juneja, Janice Smith, Pia Herrmann, Dennis Kobelt, Kamal Sharma, Iduna Fichtner, Wolfgang Walther, Gunnar Dittmar, Rudolf Volkmer, Fritz G. Rathjen, Peter M. Schlag, Ulrike SteinList of authors in order
- Landing page
-
https://doi.org/10.3389/fonc.2023.1280977Publisher landing page
- PDF URL
-
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1280977/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1280977/pdfDirect OA link when available
- Concepts
-
Metastasis, Gene knockdown, Chromatin immunoprecipitation, Cancer research, Transcription factor, Immunoprecipitation, Colorectal cancer, Biology, Electrophoretic mobility shift assay, Promoter, Chemistry, Gene, Gene expression, Cancer, GeneticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
47Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4389479645 |
|---|---|
| doi | https://doi.org/10.3389/fonc.2023.1280977 |
| ids.doi | https://doi.org/10.3389/fonc.2023.1280977 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38144523 |
| ids.openalex | https://openalex.org/W4389479645 |
| fwci | 0.38214438 |
| type | article |
| title | GIPC1 regulates MACC1-driven metastasis |
| biblio.issue | |
| biblio.volume | 13 |
| biblio.last_page | 1280977 |
| biblio.first_page | 1280977 |
| topics[0].id | https://openalex.org/T11369 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9991999864578247 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Genetic factors in colorectal cancer |
| topics[1].id | https://openalex.org/T10336 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.995199978351593 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Cells and Metastasis |
| topics[2].id | https://openalex.org/T11287 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9939000010490417 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1306 |
| topics[2].subfield.display_name | Cancer Research |
| topics[2].display_name | Cancer Genomics and Diagnostics |
| is_xpac | False |
| apc_list.value | 2950 |
| apc_list.currency | USD |
| apc_list.value_usd | 2950 |
| apc_paid.value | 3659 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 3946 |
| concepts[0].id | https://openalex.org/C2779013556 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7911339998245239 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q181876 |
| concepts[0].display_name | Metastasis |
| concepts[1].id | https://openalex.org/C173396325 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7383675575256348 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1501275 |
| concepts[1].display_name | Gene knockdown |
| concepts[2].id | https://openalex.org/C134320426 |
| concepts[2].level | 5 |
| concepts[2].score | 0.7365590333938599 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q901026 |
| concepts[2].display_name | Chromatin immunoprecipitation |
| concepts[3].id | https://openalex.org/C502942594 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6392976641654968 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[3].display_name | Cancer research |
| concepts[4].id | https://openalex.org/C86339819 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6382929086685181 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q407384 |
| concepts[4].display_name | Transcription factor |
| concepts[5].id | https://openalex.org/C71829478 |
| concepts[5].level | 3 |
| concepts[5].score | 0.49905991554260254 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q901305 |
| concepts[5].display_name | Immunoprecipitation |
| concepts[6].id | https://openalex.org/C526805850 |
| concepts[6].level | 3 |
| concepts[6].score | 0.49700286984443665 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q188874 |
| concepts[6].display_name | Colorectal cancer |
| concepts[7].id | https://openalex.org/C86803240 |
| concepts[7].level | 0 |
| concepts[7].score | 0.44426289200782776 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[7].display_name | Biology |
| concepts[8].id | https://openalex.org/C183978625 |
| concepts[8].level | 4 |
| concepts[8].score | 0.4439787268638611 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q903596 |
| concepts[8].display_name | Electrophoretic mobility shift assay |
| concepts[9].id | https://openalex.org/C101762097 |
| concepts[9].level | 4 |
| concepts[9].score | 0.42241528630256653 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q224093 |
| concepts[9].display_name | Promoter |
| concepts[10].id | https://openalex.org/C185592680 |
| concepts[10].level | 0 |
| concepts[10].score | 0.37686410546302795 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[10].display_name | Chemistry |
| concepts[11].id | https://openalex.org/C104317684 |
| concepts[11].level | 2 |
| concepts[11].score | 0.3527912497520447 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[11].display_name | Gene |
| concepts[12].id | https://openalex.org/C150194340 |
| concepts[12].level | 3 |
| concepts[12].score | 0.3240847587585449 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q26972 |
| concepts[12].display_name | Gene expression |
| concepts[13].id | https://openalex.org/C121608353 |
| concepts[13].level | 2 |
| concepts[13].score | 0.2876904010772705 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[13].display_name | Cancer |
| concepts[14].id | https://openalex.org/C54355233 |
| concepts[14].level | 1 |
| concepts[14].score | 0.11296764016151428 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[14].display_name | Genetics |
| keywords[0].id | https://openalex.org/keywords/metastasis |
| keywords[0].score | 0.7911339998245239 |
| keywords[0].display_name | Metastasis |
| keywords[1].id | https://openalex.org/keywords/gene-knockdown |
| keywords[1].score | 0.7383675575256348 |
| keywords[1].display_name | Gene knockdown |
| keywords[2].id | https://openalex.org/keywords/chromatin-immunoprecipitation |
| keywords[2].score | 0.7365590333938599 |
| keywords[2].display_name | Chromatin immunoprecipitation |
| keywords[3].id | https://openalex.org/keywords/cancer-research |
| keywords[3].score | 0.6392976641654968 |
| keywords[3].display_name | Cancer research |
| keywords[4].id | https://openalex.org/keywords/transcription-factor |
| keywords[4].score | 0.6382929086685181 |
| keywords[4].display_name | Transcription factor |
| keywords[5].id | https://openalex.org/keywords/immunoprecipitation |
| keywords[5].score | 0.49905991554260254 |
| keywords[5].display_name | Immunoprecipitation |
| keywords[6].id | https://openalex.org/keywords/colorectal-cancer |
| keywords[6].score | 0.49700286984443665 |
| keywords[6].display_name | Colorectal cancer |
| keywords[7].id | https://openalex.org/keywords/biology |
| keywords[7].score | 0.44426289200782776 |
| keywords[7].display_name | Biology |
| keywords[8].id | https://openalex.org/keywords/electrophoretic-mobility-shift-assay |
| keywords[8].score | 0.4439787268638611 |
| keywords[8].display_name | Electrophoretic mobility shift assay |
| keywords[9].id | https://openalex.org/keywords/promoter |
| keywords[9].score | 0.42241528630256653 |
| keywords[9].display_name | Promoter |
| keywords[10].id | https://openalex.org/keywords/chemistry |
| keywords[10].score | 0.37686410546302795 |
| keywords[10].display_name | Chemistry |
| keywords[11].id | https://openalex.org/keywords/gene |
| keywords[11].score | 0.3527912497520447 |
| keywords[11].display_name | Gene |
| keywords[12].id | https://openalex.org/keywords/gene-expression |
| keywords[12].score | 0.3240847587585449 |
| keywords[12].display_name | Gene expression |
| keywords[13].id | https://openalex.org/keywords/cancer |
| keywords[13].score | 0.2876904010772705 |
| keywords[13].display_name | Cancer |
| keywords[14].id | https://openalex.org/keywords/genetics |
| keywords[14].score | 0.11296764016151428 |
| keywords[14].display_name | Genetics |
| language | en |
| locations[0].id | doi:10.3389/fonc.2023.1280977 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2596394214 |
| locations[0].source.issn | 2234-943X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2234-943X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1280977/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Oncology |
| locations[0].landing_page_url | https://doi.org/10.3389/fonc.2023.1280977 |
| locations[1].id | pmid:38144523 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38144523 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10748395 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10748395/pdf/fonc-13-1280977.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Front Oncol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10748395 |
| locations[3].id | pmh:oai:doaj.org/article:f7057db6ffbe4927a16349f2de8304f9 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Frontiers in Oncology, Vol 13 (2023) |
| locations[3].landing_page_url | https://doaj.org/article/f7057db6ffbe4927a16349f2de8304f9 |
| locations[4].id | pmh:oai:refubium.fu-berlin.de:fub188/44191 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S4306402444 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | Refubium (Universitätsbibliothek der Freien Universität Berlin) |
| locations[4].source.host_organization | https://openalex.org/I75951250 |
| locations[4].source.host_organization_name | Freie Universität Berlin |
| locations[4].source.host_organization_lineage | https://openalex.org/I75951250 |
| locations[4].license | cc-by |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | doc-type:article |
| locations[4].license_id | https://openalex.org/licenses/cc-by |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | |
| locations[4].landing_page_url | https://refubium.fu-berlin.de/handle/fub188/44191 |
| locations[5].id | doi:10.17169/refubium-43901 |
| locations[5].is_oa | True |
| locations[5].source.id | https://openalex.org/S7407052913 |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver |
| locations[5].source.host_organization | |
| locations[5].source.host_organization_name | |
| locations[5].source.host_organization_lineage | |
| locations[5].license | cc-by |
| locations[5].pdf_url | |
| locations[5].version | |
| locations[5].raw_type | article-journal |
| locations[5].license_id | https://openalex.org/licenses/cc-by |
| locations[5].is_accepted | False |
| locations[5].is_published | |
| locations[5].raw_source_name | |
| locations[5].landing_page_url | https://doi.org/10.17169/refubium-43901 |
| indexed_in | crossref, datacite, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5055135489 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Franziska Siegel |
| authorships[0].countries | DE |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I205582932, https://openalex.org/I7877124 |
| authorships[0].affiliations[0].raw_affiliation_string | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[0].institutions[0].id | https://openalex.org/I7877124 |
| authorships[0].institutions[0].ror | https://ror.org/001w7jn25 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I7877124 |
| authorships[0].institutions[0].country_code | DE |
| authorships[0].institutions[0].display_name | Charité - Universitätsmedizin Berlin |
| authorships[0].institutions[1].id | https://openalex.org/I205582932 |
| authorships[0].institutions[1].ror | https://ror.org/04p5ggc03 |
| authorships[0].institutions[1].type | facility |
| authorships[0].institutions[1].lineage | https://openalex.org/I1305996414, https://openalex.org/I205582932 |
| authorships[0].institutions[1].country_code | DE |
| authorships[0].institutions[1].display_name | Max Delbrück Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Franziska Siegel |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[1].author.id | https://openalex.org/A5050734106 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4288-4257 |
| authorships[1].author.display_name | Hannes Schmidt |
| authorships[1].countries | DE |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I205582932 |
| authorships[1].affiliations[0].raw_affiliation_string | Department Developmental Neurobiology, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[1].institutions[0].id | https://openalex.org/I205582932 |
| authorships[1].institutions[0].ror | https://ror.org/04p5ggc03 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I1305996414, https://openalex.org/I205582932 |
| authorships[1].institutions[0].country_code | DE |
| authorships[1].institutions[0].display_name | Max Delbrück Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Hannes Schmidt |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department Developmental Neurobiology, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[2].author.id | https://openalex.org/A5107439936 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Manisha Juneja |
| authorships[2].countries | DE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I205582932, https://openalex.org/I7877124 |
| authorships[2].affiliations[0].raw_affiliation_string | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[2].institutions[0].id | https://openalex.org/I7877124 |
| authorships[2].institutions[0].ror | https://ror.org/001w7jn25 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I7877124 |
| authorships[2].institutions[0].country_code | DE |
| authorships[2].institutions[0].display_name | Charité - Universitätsmedizin Berlin |
| authorships[2].institutions[1].id | https://openalex.org/I205582932 |
| authorships[2].institutions[1].ror | https://ror.org/04p5ggc03 |
| authorships[2].institutions[1].type | facility |
| authorships[2].institutions[1].lineage | https://openalex.org/I1305996414, https://openalex.org/I205582932 |
| authorships[2].institutions[1].country_code | DE |
| authorships[2].institutions[1].display_name | Max Delbrück Center |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Manisha Juneja |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[3].author.id | https://openalex.org/A5085872640 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-2088-5710 |
| authorships[3].author.display_name | Janice Smith |
| authorships[3].countries | DE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I205582932, https://openalex.org/I7877124 |
| authorships[3].affiliations[0].raw_affiliation_string | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[3].institutions[0].id | https://openalex.org/I7877124 |
| authorships[3].institutions[0].ror | https://ror.org/001w7jn25 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I7877124 |
| authorships[3].institutions[0].country_code | DE |
| authorships[3].institutions[0].display_name | Charité - Universitätsmedizin Berlin |
| authorships[3].institutions[1].id | https://openalex.org/I205582932 |
| authorships[3].institutions[1].ror | https://ror.org/04p5ggc03 |
| authorships[3].institutions[1].type | facility |
| authorships[3].institutions[1].lineage | https://openalex.org/I1305996414, https://openalex.org/I205582932 |
| authorships[3].institutions[1].country_code | DE |
| authorships[3].institutions[1].display_name | Max Delbrück Center |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Janice Smith |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[4].author.id | https://openalex.org/A5028707972 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Pia Herrmann |
| authorships[4].countries | DE |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I205582932, https://openalex.org/I7877124 |
| authorships[4].affiliations[0].raw_affiliation_string | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[4].institutions[0].id | https://openalex.org/I7877124 |
| authorships[4].institutions[0].ror | https://ror.org/001w7jn25 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I7877124 |
| authorships[4].institutions[0].country_code | DE |
| authorships[4].institutions[0].display_name | Charité - Universitätsmedizin Berlin |
| authorships[4].institutions[1].id | https://openalex.org/I205582932 |
| authorships[4].institutions[1].ror | https://ror.org/04p5ggc03 |
| authorships[4].institutions[1].type | facility |
| authorships[4].institutions[1].lineage | https://openalex.org/I1305996414, https://openalex.org/I205582932 |
| authorships[4].institutions[1].country_code | DE |
| authorships[4].institutions[1].display_name | Max Delbrück Center |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Pia Herrmann |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[5].author.id | https://openalex.org/A5014889119 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-9373-0648 |
| authorships[5].author.display_name | Dennis Kobelt |
| authorships[5].countries | DE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I205582932, https://openalex.org/I7877124 |
| authorships[5].affiliations[0].raw_affiliation_string | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I17937529, https://openalex.org/I4391767962 |
| authorships[5].affiliations[1].raw_affiliation_string | German Cancer Consortium, Heidelberg, Germany |
| authorships[5].institutions[0].id | https://openalex.org/I4391767962 |
| authorships[5].institutions[0].ror | https://ror.org/02pqn3g31 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I4391767962, https://openalex.org/I4411590659 |
| authorships[5].institutions[0].country_code | |
| authorships[5].institutions[0].display_name | Deutschen Konsortium für Translationale Krebsforschung |
| authorships[5].institutions[1].id | https://openalex.org/I7877124 |
| authorships[5].institutions[1].ror | https://ror.org/001w7jn25 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I7877124 |
| authorships[5].institutions[1].country_code | DE |
| authorships[5].institutions[1].display_name | Charité - Universitätsmedizin Berlin |
| authorships[5].institutions[2].id | https://openalex.org/I17937529 |
| authorships[5].institutions[2].ror | https://ror.org/04cdgtt98 |
| authorships[5].institutions[2].type | facility |
| authorships[5].institutions[2].lineage | https://openalex.org/I1305996414, https://openalex.org/I17937529 |
| authorships[5].institutions[2].country_code | DE |
| authorships[5].institutions[2].display_name | German Cancer Research Center |
| authorships[5].institutions[3].id | https://openalex.org/I205582932 |
| authorships[5].institutions[3].ror | https://ror.org/04p5ggc03 |
| authorships[5].institutions[3].type | facility |
| authorships[5].institutions[3].lineage | https://openalex.org/I1305996414, https://openalex.org/I205582932 |
| authorships[5].institutions[3].country_code | DE |
| authorships[5].institutions[3].display_name | Max Delbrück Center |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Dennis Kobelt |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany, German Cancer Consortium, Heidelberg, Germany |
| authorships[6].author.id | https://openalex.org/A5015641023 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-5866-2566 |
| authorships[6].author.display_name | Kamal Sharma |
| authorships[6].countries | DE |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I205582932 |
| authorships[6].affiliations[0].raw_affiliation_string | Department Developmental Neurobiology, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[6].institutions[0].id | https://openalex.org/I205582932 |
| authorships[6].institutions[0].ror | https://ror.org/04p5ggc03 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I1305996414, https://openalex.org/I205582932 |
| authorships[6].institutions[0].country_code | DE |
| authorships[6].institutions[0].display_name | Max Delbrück Center |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Kamal Sharma |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department Developmental Neurobiology, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[7].author.id | https://openalex.org/A5109512554 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Iduna Fichtner |
| authorships[7].affiliations[0].raw_affiliation_string | Experimental Pharmacology and Oncology, GmbH, Berlin, Germany |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Iduna Fichtner |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Experimental Pharmacology and Oncology, GmbH, Berlin, Germany |
| authorships[8].author.id | https://openalex.org/A5031474036 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-2360-1370 |
| authorships[8].author.display_name | Wolfgang Walther |
| authorships[8].countries | DE |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I205582932, https://openalex.org/I7877124 |
| authorships[8].affiliations[0].raw_affiliation_string | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[8].institutions[0].id | https://openalex.org/I7877124 |
| authorships[8].institutions[0].ror | https://ror.org/001w7jn25 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I7877124 |
| authorships[8].institutions[0].country_code | DE |
| authorships[8].institutions[0].display_name | Charité - Universitätsmedizin Berlin |
| authorships[8].institutions[1].id | https://openalex.org/I205582932 |
| authorships[8].institutions[1].ror | https://ror.org/04p5ggc03 |
| authorships[8].institutions[1].type | facility |
| authorships[8].institutions[1].lineage | https://openalex.org/I1305996414, https://openalex.org/I205582932 |
| authorships[8].institutions[1].country_code | DE |
| authorships[8].institutions[1].display_name | Max Delbrück Center |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Wolfgang Walther |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[9].author.id | https://openalex.org/A5002715888 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-3647-8623 |
| authorships[9].author.display_name | Gunnar Dittmar |
| authorships[9].countries | DE |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I205582932 |
| authorships[9].affiliations[0].raw_affiliation_string | Department Mass Spectrometry, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[9].institutions[0].id | https://openalex.org/I205582932 |
| authorships[9].institutions[0].ror | https://ror.org/04p5ggc03 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I1305996414, https://openalex.org/I205582932 |
| authorships[9].institutions[0].country_code | DE |
| authorships[9].institutions[0].display_name | Max Delbrück Center |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Gunnar Dittmar |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department Mass Spectrometry, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[10].author.id | https://openalex.org/A5018532546 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-4710-1143 |
| authorships[10].author.display_name | Rudolf Volkmer |
| authorships[10].countries | DE |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I7877124 |
| authorships[10].affiliations[0].raw_affiliation_string | Institute for Medicinal Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany |
| authorships[10].institutions[0].id | https://openalex.org/I7877124 |
| authorships[10].institutions[0].ror | https://ror.org/001w7jn25 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I7877124 |
| authorships[10].institutions[0].country_code | DE |
| authorships[10].institutions[0].display_name | Charité - Universitätsmedizin Berlin |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Rudolf Volkmer |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Institute for Medicinal Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany |
| authorships[11].author.id | https://openalex.org/A5044800358 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5351-613X |
| authorships[11].author.display_name | Fritz G. Rathjen |
| authorships[11].countries | DE |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I205582932 |
| authorships[11].affiliations[0].raw_affiliation_string | Department Developmental Neurobiology, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[11].institutions[0].id | https://openalex.org/I205582932 |
| authorships[11].institutions[0].ror | https://ror.org/04p5ggc03 |
| authorships[11].institutions[0].type | facility |
| authorships[11].institutions[0].lineage | https://openalex.org/I1305996414, https://openalex.org/I205582932 |
| authorships[11].institutions[0].country_code | DE |
| authorships[11].institutions[0].display_name | Max Delbrück Center |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Fritz G. Rathjen |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department Developmental Neurobiology, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[12].author.id | https://openalex.org/A5109947555 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Peter M. Schlag |
| authorships[12].countries | DE |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I7877124 |
| authorships[12].affiliations[0].raw_affiliation_string | Charité Comprehensive Cancer Center, Berlin, Germany |
| authorships[12].institutions[0].id | https://openalex.org/I7877124 |
| authorships[12].institutions[0].ror | https://ror.org/001w7jn25 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I7877124 |
| authorships[12].institutions[0].country_code | DE |
| authorships[12].institutions[0].display_name | Charité - Universitätsmedizin Berlin |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Peter M. Schlag |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Charité Comprehensive Cancer Center, Berlin, Germany |
| authorships[13].author.id | https://openalex.org/A5002853916 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-7006-282X |
| authorships[13].author.display_name | Ulrike Stein |
| authorships[13].countries | DE |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I17937529, https://openalex.org/I4391767962 |
| authorships[13].affiliations[0].raw_affiliation_string | German Cancer Consortium, Heidelberg, Germany |
| authorships[13].affiliations[1].institution_ids | https://openalex.org/I205582932, https://openalex.org/I7877124 |
| authorships[13].affiliations[1].raw_affiliation_string | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany |
| authorships[13].institutions[0].id | https://openalex.org/I4391767962 |
| authorships[13].institutions[0].ror | https://ror.org/02pqn3g31 |
| authorships[13].institutions[0].type | facility |
| authorships[13].institutions[0].lineage | https://openalex.org/I4391767962, https://openalex.org/I4411590659 |
| authorships[13].institutions[0].country_code | |
| authorships[13].institutions[0].display_name | Deutschen Konsortium für Translationale Krebsforschung |
| authorships[13].institutions[1].id | https://openalex.org/I7877124 |
| authorships[13].institutions[1].ror | https://ror.org/001w7jn25 |
| authorships[13].institutions[1].type | healthcare |
| authorships[13].institutions[1].lineage | https://openalex.org/I7877124 |
| authorships[13].institutions[1].country_code | DE |
| authorships[13].institutions[1].display_name | Charité - Universitätsmedizin Berlin |
| authorships[13].institutions[2].id | https://openalex.org/I17937529 |
| authorships[13].institutions[2].ror | https://ror.org/04cdgtt98 |
| authorships[13].institutions[2].type | facility |
| authorships[13].institutions[2].lineage | https://openalex.org/I1305996414, https://openalex.org/I17937529 |
| authorships[13].institutions[2].country_code | DE |
| authorships[13].institutions[2].display_name | German Cancer Research Center |
| authorships[13].institutions[3].id | https://openalex.org/I205582932 |
| authorships[13].institutions[3].ror | https://ror.org/04p5ggc03 |
| authorships[13].institutions[3].type | facility |
| authorships[13].institutions[3].lineage | https://openalex.org/I1305996414, https://openalex.org/I205582932 |
| authorships[13].institutions[3].country_code | DE |
| authorships[13].institutions[3].display_name | Max Delbrück Center |
| authorships[13].author_position | last |
| authorships[13].raw_author_name | Ulrike Stein |
| authorships[13].is_corresponding | True |
| authorships[13].raw_affiliation_strings | Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Institute, Charité Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany, German Cancer Consortium, Heidelberg, Germany |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1280977/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2023-12-09T00:00:00 |
| display_name | GIPC1 regulates MACC1-driven metastasis |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11369 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9991999864578247 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Genetic factors in colorectal cancer |
| related_works | https://openalex.org/W1560235021, https://openalex.org/W10839406, https://openalex.org/W2564946823, https://openalex.org/W2036891548, https://openalex.org/W2899211828, https://openalex.org/W4319350362, https://openalex.org/W4239724675, https://openalex.org/W2351542508, https://openalex.org/W2471443024, https://openalex.org/W2135353249 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 6 |
| best_oa_location.id | doi:10.3389/fonc.2023.1280977 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2596394214 |
| best_oa_location.source.issn | 2234-943X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2234-943X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1280977/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fonc.2023.1280977 |
| primary_location.id | doi:10.3389/fonc.2023.1280977 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2596394214 |
| primary_location.source.issn | 2234-943X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2234-943X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1280977/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Oncology |
| primary_location.landing_page_url | https://doi.org/10.3389/fonc.2023.1280977 |
| publication_date | 2023-12-08 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W4315754639, https://openalex.org/W4322719806, https://openalex.org/W2114014236, https://openalex.org/W2907603303, https://openalex.org/W2095143857, https://openalex.org/W2670064607, https://openalex.org/W3032092952, https://openalex.org/W3017965839, https://openalex.org/W4281746488, https://openalex.org/W3125974259, https://openalex.org/W3135561803, https://openalex.org/W3214197925, https://openalex.org/W2003207814, https://openalex.org/W2234234909, https://openalex.org/W1966754581, https://openalex.org/W2125804654, https://openalex.org/W1998140525, https://openalex.org/W2124829726, https://openalex.org/W2009864060, https://openalex.org/W3114053654, https://openalex.org/W2081415074, https://openalex.org/W2088335631, https://openalex.org/W2003657314, https://openalex.org/W2164078562, https://openalex.org/W2078277807, https://openalex.org/W2084541361, https://openalex.org/W1985951459, https://openalex.org/W1970966441, https://openalex.org/W1967842430, https://openalex.org/W2109886015, https://openalex.org/W2119050497, https://openalex.org/W2048321210, https://openalex.org/W2109137601, https://openalex.org/W2103686156, https://openalex.org/W3177660183, https://openalex.org/W2110960566, https://openalex.org/W1564784444, https://openalex.org/W2114748778, https://openalex.org/W2095250075, https://openalex.org/W2180193980, https://openalex.org/W3026131022, https://openalex.org/W4210922095, https://openalex.org/W2204374538, https://openalex.org/W4281249676, https://openalex.org/W3042069114, https://openalex.org/W2620659693, https://openalex.org/W4213296330 |
| referenced_works_count | 47 |
| abstract_inverted_index., | 59 |
| abstract_inverted_index.- | 247 |
| abstract_inverted_index.a | 34 |
| abstract_inverted_index.By | 69 |
| abstract_inverted_index.In | 198 |
| abstract_inverted_index.We | 106, 132, 239 |
| abstract_inverted_index.an | 241 |
| abstract_inverted_index.as | 103, 139, 155, 248, 253 |
| abstract_inverted_index.by | 85 |
| abstract_inverted_index.in | 26, 57, 66, 112, 115, 190 |
| abstract_inverted_index.is | 7, 33, 209 |
| abstract_inverted_index.of | 2, 24, 29, 53, 143, 153, 210, 220, 245, 256 |
| abstract_inverted_index.to | 9, 158, 163 |
| abstract_inverted_index.we | 20, 79, 99, 119, 148 |
| abstract_inverted_index.-60 | 164 |
| abstract_inverted_index.CMV | 172 |
| abstract_inverted_index.CRC | 196, 201 |
| abstract_inverted_index.and | 15, 41, 51, 60, 64, 76, 91, 94, 114, 118, 135, 147, 176, 181, 188, 208, 216, 222, 252, 262 |
| abstract_inverted_index.any | 235 |
| abstract_inverted_index.but | 170 |
| abstract_inverted_index.did | 232 |
| abstract_inverted_index.for | 13, 37, 101, 111, 213, 259 |
| abstract_inverted_index.its | 136 |
| abstract_inverted_index.not | 171, 233 |
| abstract_inverted_index.the | 11, 22, 27, 87, 121, 144, 151, 159 |
| abstract_inverted_index.– | 258 |
| abstract_inverted_index.(TSS | 162 |
| abstract_inverted_index.Here | 19 |
| abstract_inverted_index.also | 149 |
| abstract_inverted_index.bp). | 165 |
| abstract_inverted_index.cell | 109, 179 |
| abstract_inverted_index.dual | 243 |
| abstract_inverted_index.gene | 46, 89 |
| abstract_inverted_index.mass | 73 |
| abstract_inverted_index.mice | 191 |
| abstract_inverted_index.role | 23 |
| abstract_inverted_index.show | 234 |
| abstract_inverted_index.vivo | 116 |
| abstract_inverted_index.with | 194, 205 |
| abstract_inverted_index.(CRC) | 129 |
| abstract_inverted_index.GIPC1 | 25, 81, 102, 154, 166, 183, 203, 223, 246 |
| abstract_inverted_index.MACC1 | 32, 44, 88, 134, 160, 174, 206, 221, 257 |
| abstract_inverted_index.array | 78 |
| abstract_inverted_index.assay | 98 |
| abstract_inverted_index.basis | 12 |
| abstract_inverted_index.cells | 56 |
| abstract_inverted_index.colon | 54 |
| abstract_inverted_index.human | 125, 199 |
| abstract_inverted_index.lines | 110 |
| abstract_inverted_index.mice. | 67 |
| abstract_inverted_index.shift | 97 |
| abstract_inverted_index.tumor | 62, 186, 260 |
| abstract_inverted_index.using | 70, 86, 124 |
| abstract_inverted_index.value | 212 |
| abstract_inverted_index.vitro | 58, 113 |
| abstract_inverted_index.GIPC1, | 146 |
| abstract_inverted_index.SH3BP4 | 138, 230 |
| abstract_inverted_index.assay, | 72 |
| abstract_inverted_index.cancer | 3, 55, 128, 263 |
| abstract_inverted_index.causes | 61 |
| abstract_inverted_index.cells. | 197 |
| abstract_inverted_index.factor | 157, 255 |
| abstract_inverted_index.growth | 63, 187 |
| abstract_inverted_index.impact | 123 |
| abstract_inverted_index.probed | 100, 120 |
| abstract_inverted_index.value. | 237 |
| abstract_inverted_index.Methods | 68 |
| abstract_inverted_index.Results | 131 |
| abstract_inverted_index.address | 21 |
| abstract_inverted_index.binding | 83, 141, 152 |
| abstract_inverted_index.desired | 8 |
| abstract_inverted_index.factor. | 105 |
| abstract_inverted_index.partner | 251 |
| abstract_inverted_index.patient | 38, 226 |
| abstract_inverted_index.peptide | 77 |
| abstract_inverted_index.primary | 126, 200 |
| abstract_inverted_index.process | 28 |
| abstract_inverted_index.protein | 82, 140, 145, 249 |
| abstract_inverted_index.provide | 10 |
| abstract_inverted_index.reduced | 168, 185 |
| abstract_inverted_index.tissue. | 130 |
| abstract_inverted_index.whereas | 229 |
| abstract_inverted_index.analyzed | 80 |
| abstract_inverted_index.controls | 45 |
| abstract_inverted_index.employed | 107 |
| abstract_inverted_index.function | 244 |
| abstract_inverted_index.improved | 225 |
| abstract_inverted_index.invasion | 50 |
| abstract_inverted_index.mobility | 96 |
| abstract_inverted_index.networks | 6 |
| abstract_inverted_index.partners | 142 |
| abstract_inverted_index.promoter | 90, 161 |
| abstract_inverted_index.promotes | 48 |
| abstract_inverted_index.survival | 227 |
| abstract_inverted_index.analyses, | 117 |
| abstract_inverted_index.chromatin | 92 |
| abstract_inverted_index.formation | 40, 215 |
| abstract_inverted_index.indicator | 36 |
| abstract_inverted_index.invasion. | 182 |
| abstract_inverted_index.knockdown | 167 |
| abstract_inverted_index.migration | 180 |
| abstract_inverted_index.molecular | 5 |
| abstract_inverted_index.motility, | 49 |
| abstract_inverted_index.paralogue | 137 |
| abstract_inverted_index.partners, | 84 |
| abstract_inverted_index.survival. | 43, 218 |
| abstract_inverted_index.Background | 0 |
| abstract_inverted_index.colorectal | 127 |
| abstract_inverted_index.correlates | 204 |
| abstract_inverted_index.developing | 16 |
| abstract_inverted_index.diminished | 177 |
| abstract_inverted_index.expression | 207, 224, 231 |
| abstract_inverted_index.identified | 133, 240 |
| abstract_inverted_index.important, | 242 |
| abstract_inverted_index.metastasis | 39, 65, 189, 214 |
| abstract_inverted_index.prognosis, | 228 |
| abstract_inverted_index.prognostic | 35, 211, 236 |
| abstract_inverted_index.specimens, | 202 |
| abstract_inverted_index.Combination | 219 |
| abstract_inverted_index.Conclusions | 238 |
| abstract_inverted_index.GIPC1/MACC1 | 122 |
| abstract_inverted_index.endogenous, | 169 |
| abstract_inverted_index.expression, | 175 |
| abstract_inverted_index.interaction | 250 |
| abstract_inverted_index.metastasis. | 31, 264 |
| abstract_inverted_index.progression | 261 |
| abstract_inverted_index.strategies. | 18 |
| abstract_inverted_index.suppression | 184 |
| abstract_inverted_index.MACC1-driven | 30 |
| abstract_inverted_index.demonstrated | 150 |
| abstract_inverted_index.intervention | 17 |
| abstract_inverted_index.transplanted | 193 |
| abstract_inverted_index.MACC1-induced | 178 |
| abstract_inverted_index.proliferation | 52 |
| abstract_inverted_index.spectrometry, | 74 |
| abstract_inverted_index.transcription | 104, 156, 254 |
| abstract_inverted_index.understanding | 14 |
| abstract_inverted_index.Identification | 1 |
| abstract_inverted_index.transcription, | 47 |
| abstract_inverted_index.electrophoretic | 95 |
| abstract_inverted_index.metastasis-free | 42, 217 |
| abstract_inverted_index.promoter-driven | 173 |
| abstract_inverted_index.intrasplenically | 192 |
| abstract_inverted_index.yeast-two-hybrid | 71 |
| abstract_inverted_index.immunoprecipitation | 93 |
| abstract_inverted_index.metastasis-relevant | 4 |
| abstract_inverted_index.MACC1-overexpressing | 195 |
| abstract_inverted_index.co-immunoprecipitation | 75 |
| abstract_inverted_index.GIPC1/MACC1-manipulated | 108 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| corresponding_author_ids | https://openalex.org/A5002853916 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 14 |
| corresponding_institution_ids | https://openalex.org/I17937529, https://openalex.org/I205582932, https://openalex.org/I4391767962, https://openalex.org/I7877124 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.4399999976158142 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.66210016 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |